V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

In Silico Modeling Co-op - In Silico Modeling

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Internship · Year-roundBoston, MA, USA

About the Job

Requirements

  • Be a Ph.D. candidate or a highly experienced Master's student studying Computational Sciences, Biology, Chemistry, or a related field.
  • Have hands-on experience with in silico modeling and structural prediction of proteins and antibodies.
  • Have hands-on experience with molecular dynamics simulation and understanding of protein-ligand and protein-protein interactions.
  • Be able to adapt and be flexible with respect to working schedule.
  • Be legally authorized to work in the United States, now and in the future.
  • Be enrolled in an advanced degree program if graduating before May 2027.
  • Be available to work full-time, 40 hours per week from January to July 2027.
  • Be familiar with modeling tools such as MOE, Maestro/Schrödinger, Desmond, GROMACS, and NAMD/VMD.

Responsibilities

  • Build workflows for protein structure prediction and contribute to understanding protein structure-function relationships.
  • Use molecular dynamics simulation tools to evaluate protein-protein and protein-excipient interactions and predict macroscopic properties such as aggregation propensity and protein solution viscosity.
  • Leverage experimental data to further refine the model and workflows.
  • Evaluate Vertex pipeline molecules with established workflows as needed.
  • Report on project progress and write analytical development protocols and method development reports.
  • Maintain written documentation, including lab notebooks and test forms.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs